Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers
Clinical trial NCT02121080 · COMPLETED
Trial details
- NCT number
- NCT02121080
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-02-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.